Novel valproic acid derivatives with potent differentiation-inducing activity in myeloid leukemia cells.
In: Leukemia research, Jg. 30 (2006-09-01), Heft 9, S. 1167
Online
academicJournal
Zugriff:
The anti-epileptic drug valproic acid harbors anti-tumoral activity in solid and leukemic tumor cell models and is currently evaluated in clinical trials. However, the plasma trough concentrations obtained in patients by common anti-epileptic dose regimens are below concentrations required for exerting anti-tumor effects in vitro. Here, we describe the identification of three novel valproic acid derivatives with superior differentiation-inducing and anti-proliferative activities in K562 bcr/abl-positive chronic myeloid leukemia cells and HL60 promyelocytic leukemia cells at achievable therapeutic VPA concentrations. These compounds reveal potent inhibition of histone deacetylase activity, induction of p21Cip/Waf expression as well as low toxicity on CD34+ bone marrow cells.
Titel: |
Novel valproic acid derivatives with potent differentiation-inducing activity in myeloid leukemia cells.
|
---|---|
Autor/in / Beteiligte Person: | Deubzer, H ; Busche, B ; Rönndahl, G ; Eikel, D ; Michaelis, M ; Cinatl, J ; Schulze, S ; Nau, H ; Witt, O |
Link: | |
Zeitschrift: | Leukemia research, Jg. 30 (2006-09-01), Heft 9, S. 1167 |
Veröffentlichung: | Oxford ; New York : Pergamon Press, 2006 |
Medientyp: | academicJournal |
ISSN: | 0145-2126 (print) |
DOI: | 10.1016/j.leukres.2006.01.009 |
Schlagwort: |
|
Sonstiges: |
|